These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 861560)
21. Pseudomembranous enterocolitis and the aetiological role of Clostridium difficile. An overview of the recent literature. Moar JJ; Silva J S Afr Med J; 1981 Oct; 60(16):623-5. PubMed ID: 7292202 [No Abstract] [Full Text] [Related]
22. Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea. Keighley MR; Burdon DW; Arabi Y; Williams JA; Thompson H; Youngs D; Johnson M; Bentley S; George RH; Mogg GA Br Med J; 1978 Dec; 2(6153):1667-9. PubMed ID: 367509 [TBL] [Abstract][Full Text] [Related]
27. The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s. Andréjak M; Schmit JL; Tondriaux A Drug Saf; 1991; 6(5):339-49. PubMed ID: 1930740 [TBL] [Abstract][Full Text] [Related]
28. Diagnosis of Clostridium difficile-associated enterocolitis in Sweden. Laboratory and epidemiological aspects. Möllby R; Nord CE; Aronsson B Scand J Infect Dis Suppl; 1980; (Suppl 22):30-6. PubMed ID: 6937945 [TBL] [Abstract][Full Text] [Related]
29. [Prevalence of Clostridium difficile and toxin A in feces of HIV infected patients]. Collignon A; Jeantils V; Cruaud P; Javoy F; Thomas M; Torlotin JC Pathol Biol (Paris); 1993 Apr; 41(4):415-20. PubMed ID: 8233645 [TBL] [Abstract][Full Text] [Related]
30. Pseudomembranous colitis caused by toxin A-negative/toxin B-positive variant strain of Clostridium difficile. Toyokawa M; Ueda A; Tsukamoto H; Nishi I; Horikawa M; Sunada A; Asari S J Infect Chemother; 2003 Dec; 9(4):351-4. PubMed ID: 14691659 [TBL] [Abstract][Full Text] [Related]
31. Cytotoxin and enterotoxin production by Clostridium difficile. Gianfrilli P; Luzzi I; Pantosti A; Occhionero M; Gentile G; Panichi G Microbiologica; 1984 Oct; 7(4):375-9. PubMed ID: 6513801 [TBL] [Abstract][Full Text] [Related]
32. Colitis caused by Clostridium difficile: a review. Weymann LH Am J Med Technol; 1982 Nov; 48(11):927-34. PubMed ID: 6758571 [TBL] [Abstract][Full Text] [Related]
34. Clostridium difficile associated with pseudomembranous colitis. Occurrence in a 12-week-old infant without prior antibiotic therapy. Adler SP; Chandrika T; Berman WF Am J Dis Child; 1981 Sep; 135(9):820-2. PubMed ID: 7282658 [TBL] [Abstract][Full Text] [Related]
35. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Bartlett JG; Moon N; Chang TW; Taylor N; Onderdonk AB Gastroenterology; 1978 Nov; 75(5):778-82. PubMed ID: 700321 [TBL] [Abstract][Full Text] [Related]
36. Pseudomembranous colitis: isolation of two species of cytotoxic clostridia and successful treatment with vancomycin. Marrie TJ; Faulkner RS; Badley BW; Hartlen MR; Comeau SA; Miller HR Can Med Assoc J; 1978 Nov; 119(9):1058-60. PubMed ID: 743667 [TBL] [Abstract][Full Text] [Related]
37. Bacitracin treatment of antibiotic-associated colitis and diarrhea caused by Clostridium difficile toxin. Chang TW; Gorbach SL; Bartlett JG; Saginur R Gastroenterology; 1980 Jun; 78(6):1584-6. PubMed ID: 7372074 [TBL] [Abstract][Full Text] [Related]
38. A micro-method for detecting toxins in pseudomembranous colitis. George RH J Clin Pathol; 1979 Mar; 32(3):303-4. PubMed ID: 429598 [No Abstract] [Full Text] [Related]